PAVmed’s PortIO™ Intraosseous Infusion System Achieves Multiple Milestones
07 nov. 2019 09h30 HE
|
PAVmed Inc.
Unprecedented six-month maintenance-free implant duration achieved FDA pre-submission meeting date supporting de novo application secured Broad method and device patents granted by USPTO NEW YORK,...
PAVmed to Hold Business Update Conference Call on November 21, 2019
06 nov. 2019 09h30 HE
|
PAVmed Inc.
NEW YORK, Nov. 06, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the...
PAVmed Secures Financing up to $14 Million for Advancement of its Lead Products to Commercialization
05 nov. 2019 07h00 HE
|
PAVmed Inc.
Extends cash runway to support multiple milestones including commercialization of two lead products NEW YORK, Nov. 05, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or...
PAVmed Reports Second Quarter 2019 Financial Results and Provides Business Update
05 sept. 2019 09h30 HE
|
PAVmed Inc.
Conference call to be held on September 5, 2019 at 4:30 p.m. Eastern time NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly...
PAVmed to Hold Business Update Conference Call on September 5, 2019
07 août 2019 09h30 HE
|
PAVmed Inc.
NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the...
PAVmed to Join Russell Microcap® Index
26 juin 2019 09h30 HE
|
PAVmed Inc.
NEW YORK, June 26, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced the Company...
PAVmed to Hold Business Update Conference Call on November 15, 2018
01 nov. 2018 07h30 HE
|
PAVmed Inc.
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the...
PAVmed to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
23 oct. 2018 07h30 HE
|
PAVmed Inc.
NEW YORK, Oct, Oct. 23, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that...
PAVmed Provides Business Update
25 juil. 2018 07h30 HE
|
PAVmed Inc.
FDA confirms receipt of CarpX 510(k) resubmission for review NEW YORK, July 25, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated,...